Monday, September 20, 2021
News

COVID-19 situation in Delhi under control, says Satyendar Jain

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | January 3, 2021 2:12:56 PM IST
Coronavirus situation in the national capital is under control, Delhi Health Minister Satyendar Jain said on Sunday.

"Currently, Delhi witnessing 494 positive cases which is the lowest number of cases since May 17, 2020. The positivity rate in the national capital has been increased up to 0.3 which means that only seven persons out of 1,000 are being tested positive for COVID-19. However, the testing is happening at a large scale," Jain stated while speaking with ANI.

The Minister also appealed to people to keep wearing masks and take precautions.

Talking about the COVID-19 vaccines that have been approved by the DCGI, the Minister said that the national capital is prepared for the vaccination process in a phased manner.

"In the first phase, healthcare workers and frontline workers will be vaccinated. There are three lakh healthcare workers and six lakh frontline workers in Delhi who will be administered with the COVID-19 vaccine," he said.

"Yesterday a dry-run has been conducted across the national capital in government, private hospitals, and dispensaries. We are preparing for 1,000 centres for the vaccination process. Of which 500 to 600 centres will start for the first phase," he said.

"We have done de-escalations in hospitals three or four days ago. The beds in Delhi hospitals reduced by 2,000 to 2,500 and private hospitals by 5,000 to 6,000. The bed occupancy rate for COVID patients is less than 2,000. Earlier we have around 18,800 beds and now we have 10,000 to 11,000 beds," he said.

COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.

"After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for the conduct of the Phase III clinical trial," said VG Somani, DCGI, during a media briefing today. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'Geological uncertainty' among reasons f...
Billy Porter brings his signature dramat...
Mumbai: 5 boys drown during Ganpati imme...
COVID-19: Assam reports 259 new cases, 7...
Bhubaneswar-based artist crafts accessor...
BJP uses Taliban, Afghanistan, Pakistan ...
More...    
 
 Top Stories
Singapore reports 1,012 new Covid-1... 
Lucia Aniello wins Emmy for directi... 
Jean Smart wins Emmy for 'Outstandi... 
Meeting with VP Kamala Harris, Appl... 
Emmys 2021: Cedric the Entertainer ... 
No match for 'Ted Lasso' at Emmys, ... 
'Schitt's Creek' cast reunites at E... 
Maharashtra: BJP leader Kirit Somai...